AGP Picks
View all

Middle East Business Channel: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Business Channel.

Press releases published on July 6, 2026

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
Celestica Q2 2026 Financial Results and Conference Call Tuesday, July 28, 2026
Lamar Advertising Company to Release Second Quarter Ended June 30, 2026 Operating Results
Lowey Dannenberg, P.C. is Investigating York Space Systems, Inc. (NYSE: YSS) for Potential Violations of the Federal Securities Laws
SRAD 11-DAY DEADLINE ALERT: HBSS Investigates Sportradar Group AG (SRAD) Securities Class Action Claims After Short Seller Reports Expose Alleged Illegal Gambling Ties
SEALSQ Corp Reports Preliminary H1 2026 Results; Revenue up 120%, FY 2026 Guidance Reaffirmed
Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker
Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes
Lowey Dannenberg, P.C. is Investigating The Ensign Group (NASDAQ: ENSG) for Potential Violations of the Federal Securities Laws
Abivax Announces Closing of $920 Million Public Offering
Abivax annonce la réalisation de son offre au public de 920 millions de dollars
Sprout Social to Announce Second Quarter 2026 Financial Results on August 6, 2026
PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of Third Fiscal Quarter 2026 Results
PennantPark Investment Corporation Schedules Earnings Release of Third Fiscal Quarter 2026 Results
Valley National Bancorp to Announce Second Quarter 2026 Earnings
Kalaris Appoints Laurie Keating to Board of Directors
Longeveron® Appoints Marie Washburn as Chief Financial Officer
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Navitas Semiconductor to Report Q2 2026 Financial Results on Monday, July 27, 2026
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Business Channel

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.